Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTZPFCG)

DTT Name	CD47-SHPS1 interaction (CD47-SHPS1 PPI)
Gene Name	CD47-SHPS1 PPI
DTT Type	Clinical trial target	[1]
UniProt ID	CD47_HUMAN-SHPS1_HUMAN
TTD ID	T63204

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

1 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PF-07901801	DMEVYHR	Diffuse large B-cell lymphoma	2A81	Phase 2	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT05626322) A PHASE 1b/2 STUDY OF PF-07901801, A CD47 BLOCKING AGENT, WITH TAFASITAMAB AND LENALIDOMIDE FOR PARTICIPANTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA NOT ELIGIBLE FOR STEM CELL TRANSPLANTATION. U.S.National Institutes of Health.